Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mohammad Azab currently holds 5,500 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mohammad Azab has been a net buyer of XENE stock. They have purchased $105.0K and sold $214 worth of shares.
Mohammad Azab's most recent insider trade was on Sep 11, 2025, when they sold 6,000 shares at $0.00 per share.
Mohammad Azab serves as Executive at Xenon Pharmaceuticals Inc. (XENE). They have executed 33 insider transactions totaling $105.2K over their tenure at the company.
Mohammad Azab holds the position of Executive at Xenon Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Mohammad Azab has shown a buying trading pattern, with $105.0K in total purchases and $214 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Mohammad Azab was on Sep 15, 2022, when they purchased $120.0K worth of LSTA shares. This transaction involved 19,200 shares at $6.25 per share.
Mohammad Azab currently owns 5,500 shares of Xenon Pharmaceuticals Inc. (XENE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mohammad Azab's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mohammad Azab has 33 Form 4 filings on record as an insider at Xenon Pharmaceuticals Inc..
Set alerts for Mohammad Azab and 40,000+ other insiders.